NCT04012944

SIRONA 2 Trial Heart Failure NYHA Class III

← Hub

Registry fields

Overall status: ACTIVE_NOT_RECRUITING
Conditions: Heart Failure NYHA Class III
Study type: INTERVENTIONAL
Phase: NA
Primary purpose: DIAGNOSTIC
Intervention type: DEVICE
Interventions: Cordella™ Pulmonary Artery Sensor System
Lead sponsor: Endotronix, Inc. (INDUSTRY)

Cached at: 2026-07-28 02:39:06

View on ClinicalTrials.gov

Brief summary

This is a prospective, multi-center, open-label, single-arm CE-Mark trial to assess device safety and efficacy of the Cordella PA Sensor System in up to 75 New York Heart Association (NYHA) Class III Heart Failure patients who will receive the Cordella PA Sensor Implant.

Contact

Need a report or Korean medical writing based on this trial?

Request a report Medical writing Custom research report